Telangana

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
ABDUL KHALID QUADRI*, MD. BARKATH ALI SHAMS
Department of Pharmacy practice, Deccan School of Pharmacy, Hyderabad-500001, Telangana, India
*a.k.quadri4all@gmail.com

ABSTRACT
The Indian pharmaceutical industry is amongst the largest producer of pharmaceutical products in the world (by volume). The pharmaceutical sector is witnessing high growth rate over the past 8-10 years, it has been burdened with diminishing margins. The Indian pharmaceutical industry is facing pressures of increasing span control on account of changing regulations. GST which embodies the principle of one nation, one tax, one market is aimed at unifying the country’s INRs 124.9 trillion economy and 1.3 billion people into a common market. For corporates, the elimination of multiple taxes will improve the ease of doing business. And for consumers the biggest advantage would be in terms of reduction in overall tax burden on goods. In other words GST would make doing business in the country tax-neutral, irrespective of the choice of place of doing business, the important roll-out of GST is to provide a method for companies to simplify their operations, and achieve better efficiencies enabling them to serve customers better. It is also expected that supply chain and other operational planning opportunities and efficiencies may be available, depending on a company’s facts. However, in short–term/transitional phase, pharmaceutical industry, are likely to face a number of challenges, including possibly negative financial impacts, the need to assess existing supply chain structures, the need for reconfiguration of  IT systems and more. The warehouse cost can be reduced and rationalized the supply cahin, it has a negative effect on ayurvedic products as its rate will increase from the present rate because of increase in tax slab. GST is expected to fetch a good revenue through increase in medical tourism, GST is surely going to benefit the pharmaceutical industries. It will create a level playing field for generic drug makers, boost medical tourism and simplify the tax structure.

Indian Institute of Chemical Technology, Hyderabad is a premier R&D Institute in India. The Institute had its origin as the Central Laboratories for Scientific & Industrial Research (CLSIR), established in 1944 by the then Government of Hyderabad State. After integration of Hyderabad State with the Indian Union, the laboratory expanded with its growing activities. The main building was formally opened by Pandit Jawaharlal Nehru, the then Prime Minister of India on January 2, 1954. In 1956, the Central Laboratories came under the aegis of the Council of Scientific & Industrial Research (CSIR), New Delhi and was renamed Regional Research Laboratory, Hyderabad (RRL-H).

Post : Junior Research Fellow

NIAB is aimed to harness novel and emerging biotechnologies and take up research in the cutting edge areas for improving animal health and productivity. The Institute's focus of research will be on Animal Genetics and Genomics, Transgenic Technology, Reproductive Biotechnology, Infectious Diseases, Bioinformatics and Nutrition Enrichment. The institute aims at translational research leading to the development of novel vaccines, diagnostics and improved therapeutic molecules for farm animals. The Institute plans to promote bio entrepreneurship by providing support environment for commercial tenants involved in the development of farm animal based products.

Applications are invited from suitable candidates for filling up a position at National Institute of Animal Biotechnology (NIAB), Hyderabad.

Gland Institute of Pharmaceutical Sciences which was established in 2009 sponsored by Gland Pharma Ltd. One of the Leading Pharmaceutical company.The college was founded and governed by PVN Raju Educational Society.

Post: ASSISTANT PROFESSORS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Muthyala Nagavamsidhar*¹, Qadrie ZL.², Suman A.¹
*¹ Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Suryapet, Hyderabad, Telangana, India
nagavamsi.muthyala@gmail.com

ABSTRACT:  Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. The WHO has rated migraine amongst the top 20 most disabling life time conditions. Migraine is a pervasive and debilitating, chronic neurological painful disorder, affecting from 15% to 29% of the general population. It is the second most common cause of headache characterized by recurrent episodes of headache and associated symptoms i.e. nausea, sensitivity to light and noise that typically last from 4 to 72 hours which is divided into four phases. Migraine is well explained with three hypothesis i.e., vascular, platelet, central nervous system. It affects people of all groups, sexes, races and social classes around the globe. Migraine can occur due to various trigger factors and can be managed with both pharmacological and non-pharmacological treatment.

[adsense:336x280:8701650588]

My Health Pharmacy is a first-of-its-kind pharmacy chain. Its unique value proposition is that it is not just a pharmacy store, but a health partner to its varied customers. Started in 2012, it is currently running with 14 outlets and has big plans of expansion. My Health Pharmacy assures quality health care along with having customer friendly home delivery and counseling services The employees here are the Health Partners, who are qualified and professional pharmacists.

Post : job postings for Pharmacists

Asian Clinical Trials (ACT) is a full-fledged CRO providing complete solutions for global pharmaceutical, biotechnology and medical device companies in clinical research. ACT aims to maximize customer value by providing high quality, cost effective, professionalized services.

Post : Clinical Research Associate

Asian Clinical Trials (ACT) is a full-fledged CRO providing complete solutions for global pharmaceutical, biotechnology and medical device companies in clinical research. ACT aims to maximize customer value by providing high quality, cost effective, professionalized services.

Post : Sr. Clinical Research Associate

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post : MANAGER / DEPUTY MANAGER (OPERATIONS)